These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A randomized double-blind trial of two low dose combined oral contraceptives.
    Author: Bounds W, Vessey M, Wiggins P.
    Journal: Br J Obstet Gynaecol; 1979 Apr; 86(4):325-9. PubMed ID: 373792.
    Abstract:
    Fifty-five women using Loestrin-20 (20 microgram ethinyl oestradiol and 1 mg norethisterone acetate) as an oral contraceptive have been compared with a like number using Microgynon-30 (30 microgram ethinyl oestradiol and 150 microgram levonorgestrel) in a randomized, double-blind trial. Despite the small sample size, the main finding in the trial is clear-cut; Loestrin-20 provides poor cycle control and is thus less acceptable as an oral contraceptive than Microgynon-30. Although there is also a suggestion that Loestrin-20 may be less effective than Microgynon-30, the difference in the accidental pregnancy rates is not statistically significant. A multicenter randomized double-blind trial was conducted to compare 55 women using Loestrin-20 (20 ug ethinyl estradiol and 1 mg norethisterone acetate) as an oral contraceptive with a like number of women using Microgynon-30 (30 ug ethinyl estradiol and 150 ug levonorgestrel). 7 family planning clinics agreed to collaborate in the trial and enrollment of patients which began in November 1974. The number of participating clinics was increased to 12 at a later date. 133 patients were recruited between November 1974 and September 1976. 23 were excluded from the analysis. 55 of the remaining 110 patients were admitted to each of the 2 treatment groups. It was found that women who used Loestrin-20 discontinued treatment because of abnormal bleeding more frequently that women using Microgynon-30, but that the discontinuation rates for other reasons were closely similar in the 2 treatment groups. Of the 13 women who stopped using Loestrin-20 because of abnormal bleeding, 6 complained of oligomenorrhea or amenorrhea while the other 7 complained of irregular bleeding. Of the 2 women who stopped using Microgynon-30 because of bleeding problems, 1 complained that the bleeding was irregular and the other that it was prolonged. Although the sample size is small, Loestrin-20 clearly provides poor cycle control and consequently is less acceptable than Microgynon-30. Loestrin-20 may be less effective than Microgynon-30, but the difference in the accidental pregnacy rates is not statistically significant.
    [Abstract] [Full Text] [Related] [New Search]